Neurocrine Biosciences stock price
뉴로크린 바이오사이언시스NASDAQ:NBIX · Nasdaq · HealthcareToday's signals · RSI rebound, MACD bullish cross
Signal details →Neurocrine Biosciences last closed at $143.18 (+1.76%) on 2026-10-02. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 21.1×. Its overall grade ranks 216 of 739 stocks in Healthcare.
About this company
Neurocrine Biosciences last closed at $143.18 (+1.76%) on 2026-10-02. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 216/739
Valuation grade F
Related stocks
- AbbVieCustomer
Neurocrine의 VMAT2 억제제 Ingrezza 관련 상업화/유통 파트너로 핵심 고객 관계
- Takeda PharmaceuticalCustomer
Neurocrine의 호르몬/신경계 치료제 공동개발·상업화 이력으로 중요한 파트너
- Teva PharmaceuticalCompetitor
틱증·운동장애 및 신경정신과 영역에서 경쟁하는 제약사
ETFs holding this stock
AdvisorShares Psychedelics ETF · iShares Morningstar Small-Cap Growth ETF
Details →About Neurocrine Biosciences
- What technical signals does Neurocrine Biosciences (NBIX) have?
- Neurocrine Biosciences current technical signals: RSI rebound, MACD bullish cross.
- Is Neurocrine Biosciences a cup-and-handle pattern?
- No. Neurocrine Biosciences has no valid Cup signal right now.
- What published figures are available for Neurocrine Biosciences?
- Market cap: $14.28B. Trailing 12 months PER: 21.1×. Latest quarter PBR: 4.04×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Neurocrine Biosciences, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).